ASSOCIATION BETWEEN IMPAIRED GLUCOSE-TOLERANCE AND CIRCULATING CONCENTRATION OF LP(A) LIPOPROTEIN IN RELATION TO CORONARY HEART-DISEASE

被引:7
|
作者
FARRER, M
GAME, FL
ALBERS, CJ
NEIL, HAW
WINOCOUR, PH
LAKER, MF
ADAMS, PC
ALBERTI, KGMM
机构
[1] ROYAL VICTORIA INFIRM,DEPT CARDIOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[3] UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX2 6HE,ENGLAND
[4] UNIV NEWCASTLE UPON TYNE,DEPT MED,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源
BRITISH MEDICAL JOURNAL | 1993年 / 307卷 / 6908期
基金
英国惠康基金;
关键词
D O I
10.1136/bmj.307.6908.832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To examine whether impaired glucose tolerance and raised Lp(a) lipoprotein concentrations are associated in subjects with coronary artery disease. Design-Study of two subject populations, one with and one without symptomatic coronary artery disease. Case-control analysis of patients with impaired glucose tolerance and normal glucose tolerance performed in each subject population independently. Setting-A general practice and a hospital ward in Newcastle upon Tyne. Subjects-517 apparently healthy subjects, 13 with impaired glucose tolerance, and 245 patients who had undergone coronary artery bypass graft surgery 12 months before, 51 with impaired glucose tolerance. Main outcome measures-Serum Lp(a) lipoprotein concentration, plasma glucose concentration before and after oral challenge with 75 g glucose monohydrate, and Lp(a) lipoprotein isoforms. Results-In both the asymptomatic subjects and the subjects with coronary artery disease there was no significant difference between subjects with impaired glucose tolerance and subjects with normal glucose tolerance who were matched for age, sex, and body mass index in serum Lp(a) lipoprotein concentrations (geometric mean 61 (geometric SD 4) mg/l v 83 (5) mg/l for asymptomatic subjects, 175 (3) v 197 (2) for subjects with heart disease), nor was there any difference in the proportion of subjects who had Lp(a) lipoprotein concentrations >300 mg/l (31% v 23% for asymptomatic subjects, 37% v 37% for subjects with heart disease). For both subject groups there was no significant correlation between Lp(a) lipoprotein concentration and plasma glucose concentration after a glucose tolerance test, nor did Lp(a) lipoprotein concentration vary by quintile of glucose concentration after the test. Examination of Lp(a) lipoprotein isoforms in the subjects with coronary artery disease revealed an inverse relation between isoform size and plasma Lp(a) lipoprotein concentration, but there was no evidence that impaired glucose tolerance was associated with particular Lp(a) lipoprotein isoforms. Conclusion-Raised Lp(a) lipoprotein concentrations are not responsible for the association between impaired glucose tolerance and coronary artery disease.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [31] RELATION BETWEEN BASELINE LIPID AND LIPOPROTEIN VALUES AND THE INCIDENCE OF CORONARY HEART-DISEASE IN THE HELSINKI HEART-STUDY
    MANNINEN, V
    HUTTUNEN, JK
    HEINONEN, OP
    TENKANEN, L
    FRICK, MH
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (16): : H42 - H47
  • [32] SPECIFIC LP(A)-LIPOPROTEIN AS ADDITIONAL GENETIC-MARKERS IN THE DIAGNOSIS OF CORONARY HEART-DISEASE
    NIKITIN, YP
    TIKHONOV, AV
    KARDIOLOGIYA, 1984, 24 (02) : 29 - 32
  • [33] LACK OF ASSOCIATION BETWEEN LIPOPROTEIN (A) (LP(A)) CONCENTRATIONS AND CORONARY HEART-DISEASE MORTALITY IN DIABETES - THE WISCONSIN EPIDEMIOLOGIC-STUDY OF DIABETIC-RETINOPATHY
    HAFFNER, SM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (07) : 741 - 741
  • [34] Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance
    Ghanbari, Aline Azizi
    Doerr, Rolf
    Spitzer, Stefan
    Stumpf, Juergen
    Britz, Andreas
    Amann-Zalan, Ildiko
    Lodwig, Volker
    Ulm, Bernhard
    Schnell, Oliver
    Lohmann, Tobias
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (05): : 452 - 458
  • [35] Relation between impaired glucose metabolism and coronary artery disease
    Gotsis, AK
    Bozia, PI
    Karakiriou, MK
    Labrou, AD
    Marinos, EE
    Karagkiozaki, VC
    Papagianni, AE
    Borghi, LF
    Haritos, SD
    Panagiotidou, AE
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 122 - 122
  • [36] THE LONGITUDINAL RELATION BETWEEN CARDIOVASCULAR RISK-FACTORS AND IMPAIRED GLUCOSE-TOLERANCE - THE HOORN STUDY
    NIJPELS, G
    POPPSANIJDERS, C
    BOUTER, LM
    HEINE, RJ
    DIABETOLOGIA, 1995, 38 : A188 - A188
  • [37] ORAL-CONTRACEPTIVES AND CORONARY HEART-DISEASE - MODULATION OF GLUCOSE-TOLERANCE AND PLASMA-LIPID RISK-FACTORS BY PROGESTINS
    CROOK, D
    GODSLAND, IF
    WYNN, V
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (06) : 1612 - 1620
  • [38] ASSOCIATION BETWEEN PLASMA VISCOSITY AND CHRONIC CORONARY HEART-DISEASE
    KOENIG, W
    SUND, M
    ERNST, E
    STIEBER, J
    KEIL, U
    HOMBACH, V
    CIRCULATION, 1990, 81 (02) : 729 - 729
  • [39] FATIGUE AND HEART-DISEASE - THE ASSOCIATION BETWEEN VITAL EXHAUSTION AND PAST, PRESENT AND FUTURE CORONARY HEART-DISEASE
    APPELS, A
    MULDER, P
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1989, 33 (06) : 727 - 738
  • [40] STUDY ON CARBOHYDRATE AND LIPID-METABOLISM IN CASES OF HYPERLIPIDEMIA AND CORONARY HEART-DISEASE .1. GLUCOSE-TOLERANCE TEST AND LIPID TOLERANCE-TEST
    不详
    CHINESE MEDICAL JOURNAL, 1978, 4 (06) : 465 - 471